Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 1.53% today. In the last week its performance is 2.73%, and 7.08% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 71.28, so today’s gain of 1.53% is a significant step towards its target price. The GAP today is therefore 0.03%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 106119.45, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.90%.
At the current price of 65.08, it has a dividend yield of 3.50%, and its target price is 71.28. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 18.66, as well as a forward P/E of 11.49.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 17.71%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.25%.
Performance for the year is 17.70%. Since its IPO date on 1/2/2013, the total performance to date is 13.06%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 5378700, while its average volume is 7143.27. Whilst the total gain today was 1.53%, it did have a day high of -4.46%.
Volatility for this week has been at 1.41%, and 1.47% for the month. The 52-week low for AbbVie Inc., ABBV has been 47.37%, while the 52-week-high has reached -4.46%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.15, and the P/S is 4.29, along with a P/B of 18.76. Meanwhile it has a p/cash of 13.26.